Suppression of MKL1 promotes adipocytic differentiation and reduces the proliferation of myxoid liposarcoma cells

Kamikawa,Yohei; Yokota,Kento; Oikawa,Kosuke; Sato,Fuyuki; Muragaki,Yasuteru

doi:10.3892/ol.2020.12232

Suppression of MKL1 promotes adipocytic differentiation and reduces the proliferation of myxoid liposarcoma cells

Authors:
- Yohei Kamikawa
- Kento Yokota
- Kosuke Oikawa
- Fuyuki Sato
- Yasuteru Muragaki
View Affiliations

Affiliations: Department of Pathology, Wakayama Medical University, Wakayama 641‑8509, Japan
Published online on: October 19, 2020 https://doi.org/10.3892/ol.2020.12232
Article Number: 369

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Myxoid liposarcoma (MLS) is thought to occur due to defective adipocytic differentiation in mesenchymal stem cells. A promising strategy for MLS treatment is the prevention of sarcomagenesis by promoting the terminal differentiation of MLS cells into adipocytes. Previous studies have reported that the suppression of megakaryoblastic leukemia 1 (MKL1) expression induces adipocytic differentiation in preadipocyte cell lines. The present study aimed to investigate the effects of MKL1 suppression on MLS cells. In the present study, MKL1 knockdown was demonstrated to promote the adipocytic differentiation of an MLS‑derived cell line, designated 1955/91, under adipogenic conditions. This suggests that therapeutic targeting of the MKL1‑associated molecular pathway has potential as a promising method of MLS treatment. However, the induction of adipogenesis by MKL knockdown was incomplete, and Oil Red O staining indicated that intracellular lipid droplets were only sporadically generated. Conversely, MKL1 knockdown reduced the growth of the MLS cells. As adipocytic differentiation in vitro requires cellular confluence, the decreased growth rate of the MLS cells following MKL1 knockdown could be attributed to the incomplete induction of adipogenesis. Translocated in liposarcoma‑CCAAT/enhancer‑binding protein homologous protein (TLS‑CHOP) is an MLS‑specific oncoprotein that is thought to play key roles in sarcomagenesis and the suppression of adipocytic differentiation. However, the results of western blotting analyses suggest that TLS‑CHOP has limited effects on MKL1 expression in MLS cells and that MKL1 knockdown hardly affects TLS‑CHOP expression. Thus, it is postulated that the inhibitory effect of TLS‑CHOP on adipogenesis is not associated with MKL1 expression. However, MKL1 and the molecular pathway involving MKL1 appear to be attractive targets for the differentiation therapy of MLS.

View Figures

View References

1	He BC, Chen L, Zuo GW, Zhang W, Bi Y, Huang J, Wang Y, Jiang W, Luo Q, Shi Q, et al: Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res. 16:2235–2245. 2010. View Article : Google Scholar : PubMed/NCBI
2	Aubin JE: Regulation of osteoblast formation and function. Rev Endocr Metab Disord. 2:81–94. 2001. View Article : Google Scholar : PubMed/NCBI
3	Luu HH, Song WX, Luo X, Manning D, Luo J, Deng ZL, Sharff KA, Montag AG, Haydon RC and He TC: Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res. 25:665–677. 2007. View Article : Google Scholar : PubMed/NCBI
4	Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X, Chen J, Bennett E, Reid R, Manning D, et al: Regulation of osteogenic differentiation during skeletal development. Front Biosci. 13:2001–2021. 2008. View Article : Google Scholar : PubMed/NCBI
5	Reya T, Morrison SJ, Clarke MF and Weissman IL: Stem cells, cancer, and cancer stem cells. Nature. 414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
6	Luther G, Rames R, Wagner ER, Zhu G, Luo Q, Bi Y, Kim SH, Gao JL, Huang E, Yang K, et al: Molecular basis of differentiation therapy for soft tissue sarcomas. Trends Cancer Res. 6:69–90. 2010.PubMed/NCBI
7	Fritchie KJ, Goldblum JR, Tubbs RR, Sun Y, Carver P, Billings SD and Rubin BP: The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: Implications for diagnosis on small biopsy specimens. Am J Clin Pathol. 137:229–239. 2012. View Article : Google Scholar : PubMed/NCBI
8	Dal Cin P, Sciot R, Panagopoulos I, Aman P, Samson I, Mandahl N, Mitelman F, Van den Berghe H and Fletcher CD: Additional evidence of a variant translocation t(12;22) with EWS-CHOP fusion in myxoid liposarcoma: Clinicopathologic features. J Pathol. 182:437–441. 1997. View Article : Google Scholar : PubMed/NCBI
9	Loubignac F, Bourtoul C and Chapel F: Myxoid liposarcoma: A rare soft tissue tumor with a misleading benign appearance. World J Surg Oncol. 7:422009. View Article : Google Scholar : PubMed/NCBI
10	Forni C, Minuzzo M, Virdis E, Tamborini E, Simone M, Tavecchio M, Erba E, Grosso F, Gronchi A, Aman P, et al: Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. Mol Cancer Ther. 8:449–457. 2009. View Article : Google Scholar : PubMed/NCBI
11	Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN and Matushansky I: PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma. J Clin Invest. 122:886–898. 2012. View Article : Google Scholar : PubMed/NCBI
12	Oikawa K, Mizusaki A, Takanashi M, Ozaki T, Sato F, Kuroda M and Muragaki Y: PRG4 expression in myxoid liposarcoma maintains tumor cell growth through suppression of an antitumor cytokine IL-24. Biochem Biophys Res Commun. 485:209–214. 2017. View Article : Google Scholar : PubMed/NCBI
13	Gomez EW, Chen QK, Gjorevski N and Nelson CM: Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J Cell Biochem. 110:44–51. 2010.PubMed/NCBI
14	Connelly JT, Gautrot JE, Trappmann B, Tan DW, Donati G, Huck WT and Watt FM: Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions. Nat Cell Biol. 12:711–718. 2010. View Article : Google Scholar : PubMed/NCBI
15	Selvaraj A and Prywes R: Megakaryoblastic leukemia-1/2, a transcriptional co-activator of serum response factor, is required for skeletal myogenic differentiation. J Biol Chem. 278:41977–41987. 2003. View Article : Google Scholar : PubMed/NCBI
16	Esnault C, Stewart A, Gualdrini F, East P, Horswell S, Matthews N and Treisman R: Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev. 28:943–958. 2014. View Article : Google Scholar : PubMed/NCBI
17	Kalita K, Kharebava G, Zheng JJ and Hetman M: Role of megakaryoblastic acute leukemia-1 in ERK1/2-dependent stimulation of serum response factor-driven transcription by BDNF or increased synaptic activity. J Neurosci. 26:10020–10032. 2006. View Article : Google Scholar : PubMed/NCBI
18	Kalita K, Kuzniewska B and Kaczmarek L: MKLs: Co-factors of serum response factor (SRF) in neuronal responses. Int J Biochem Cell Biol. 44:1444–1447. 2012. View Article : Google Scholar : PubMed/NCBI
19	Nobusue H, Onishi N, Shimizu T, Sugihara E, Oki Y, Sumikawa Y, Chiyoda T, Akashi K, Saya H and Kano K: Regulation of MKL1 via actin cytoskeleton dynamics drives adipocyte differentiation. Nat commun. 5:33682014. View Article : Google Scholar : PubMed/NCBI
20	Rosenwald M, Efthymiou V, Opitz L and Wolfrum C: SRF and MKL1 independently inhibit brown adipogenesis. PLoS One. 12:e01706432017. View Article : Google Scholar : PubMed/NCBI
21	Ma Z, Morris SW, Valentine V, Li M, Herbrick JA, Cui X, Bouman D, Li Y, Mehta PK, Nizetic D, et al: Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet. 28:220–221. 2001. View Article : Google Scholar : PubMed/NCBI
22	Mercher T, Coniat MB, Monni R, Mauchauffe M, Nguyen Khac F, Gressin L, Mugneret F, Leblanc T, Dastugue N, Berger R and Bernard OA: Involvement of a human gene related to the drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA. 98:5776–5779. 2001. View Article : Google Scholar : PubMed/NCBI
23	Oikawa K, Ohbayashi T, Kiyono T, Nishi H, Isaka K, Umezawa A, Kuroda M and Mukai K: Expression of a novel human gene, human wings apart-like (hWAPL), is associated with cervical carcinogenesis and tumor progression. Cancer Res. 64:3545–3549. 2004. View Article : Google Scholar : PubMed/NCBI
24	Oikawa K, Tanaka M, Itoh S, Takanashi M, Ozaki T, Muragaki Y and Kuroda M: A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression. Br J Cancer. 106:1976–1979. 2012. View Article : Google Scholar : PubMed/NCBI
25	Varney SD, Betts CB, Zheng R, Wu L, Hinz B, Zhou J and Van De Water L: Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation. J Cell Sci. 129:774–787. 2016. View Article : Google Scholar : PubMed/NCBI
26	Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, Teshima S, Rokutan K, Mukai K and Kuroda M: Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem Biophys Res Commun. 290:984–987. 2002. View Article : Google Scholar : PubMed/NCBI
27	Oikawa K, Ishida T, Imamura T, Yoshida K, Takanashi M, Hattori H, Ishikawa A, Fujita K, Yamamoto K, Matsubayashi J, et al: Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas. Am J Surg Pathol. 30:351–356. 2006. View Article : Google Scholar : PubMed/NCBI
28	Tontonoz P, Hu E, Graves RA, Budavari AI and Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1224–1234. 1994. View Article : Google Scholar : PubMed/NCBI
29	Chawla A, Schwarz EJ, Dimaculangan DD and Lazar MA: Peroxisome proliferator-activated receptor (PPAR) gamma: Adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 135:798–800. 1994. View Article : Google Scholar : PubMed/NCBI
30	Guo L, Li X and Tang QQ: Transcriptional regulation of adipocyte differentiation: A central role for CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 290:755–761. 2015. View Article : Google Scholar : PubMed/NCBI
31	Batchvarova N, Wang XZ and Ron D: Inhibition of adipogenesis by the stressinduced protein CHOP (Gadd153). EMBO J. 14:4654–4661. 1995. View Article : Google Scholar : PubMed/NCBI
32	Kuroda M, Ishida T, Takanashi M, Satoh M, Machinami R and Watanabe T: Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am J Pathol. 151:735–744. 1997.PubMed/NCBI
33	Rosen ED and Spiegelman BM: Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 16:145–171. 2000. View Article : Google Scholar : PubMed/NCBI
34	Gregoire FM, Smas CM and Sul HS: Understanding adipocyte differentiation. Physiol Rev. 78:783–809. 1998. View Article : Google Scholar : PubMed/NCBI
35	Juríková M, Danihel Ľ, Polák Š and Varga I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016. View Article : Google Scholar : PubMed/NCBI
36	Malhotra U, Zaidi AH, Kosovec JE, Kasi PM, Komatsu Y, Rotoloni CL, Davison JM, Irvin CR, Hoppo T, Nason KS, et al: Prognostic value and targeted inhibition of survivin expression in esophageal adenocarcinoma and cancer-adjacent squamous epithelium. PLoS One. 8:e783432013. View Article : Google Scholar : PubMed/NCBI
37	Oyadomari S and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11:381–389. 2004. View Article : Google Scholar : PubMed/NCBI
38	Spiegelman BM and Farmer SR: Decreases in tubulin and actin gene expression prior to morphological differentiation of 3T3 adipocytes. Cell. 29:53–60. 1982. View Article : Google Scholar : PubMed/NCBI
39	Arsenijevic T, Gre´goire F, Delforge V, Delporte C and Perret J: Murine 3T3-L1 adipocyte cell differentiation model: Validated reference genes for qPCR gene expression analysis. PLoS One. 7:e375172012. View Article : Google Scholar : PubMed/NCBI
40	Zhang J, Tang H, Zhang Y, Deng R, Shao L, Liu Y, Li F, Wang X and Zhou L: Identification of suitable reference genes for quantitative RT-PCR during 3T3-L1 adipocyte differentiation. Int J Mol Med. 33:1209–1218. 2014. View Article : Google Scholar : PubMed/NCBI
41	Gentile AM, Lhamyani S, Coín-Aragüez L, Oliva-Olivera W, Zayed H, Vega-Rioja A, Monteseirin J, Romero-Zerbo SY, Tinahones FJ, Bermúdez-Silva FJ and Bekay RE: RPL13A and EEF1A1 are suitable reference genes for qPCR during adipocyte differentiation of vascular stromal cells from patients with different BMI and HOMA-IR. PLoS One. 11:e01570022016. View Article : Google Scholar : PubMed/NCBI
42	Kuroda M, Wang X, Sok J, Yin Y, Chung P, Giannotti JW, Jacobs KA, Fitz LJ, Murtha-Riel P, Turner KJ and Ron D: Induction of a secreted protein by the myxoid liposarcoma oncogene. Proc Natl Acad Sci USA. 96:5025–5030. 1999. View Article : Google Scholar : PubMed/NCBI
43	Perez-Mancera PA, Bermejo-Rodrıguez C, Sanchez-Martin M, Abollo-Jimenez F, Pintado B and Sanchez-Garcıa I: FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E. PLoS One. 3:e25692008. View Article : Google Scholar : PubMed/NCBI
44	Andersson MK, Goransson M, Olofsson A, Andersson C and Aman P: Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop. BMC Cancer. 10:2492010. View Article : Google Scholar : PubMed/NCBI